About Us
Science Programs
Pipeline
Clinical Trials
Careers
cONTACT
Resources
Corporate Presentation
Posters, PRESENTATIONS & Publications
MEDIA
Events
News & press releases
Investors
Overview
Stock Information
Analyst Coverage
Stock Quote & Chart
Historical Price Lookup
Investment Calculator
Financials & SEC FILINGS
Sec Filings
Quarterly Results
cORPORATE GOVERNANCE
Management Team
Board of Directors
Committee Composition
Governance Documents
News & Press Releases
Get up to speed with Rain!
Filter by year...
2022
2021
2020
2019
2018
Reset Filter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
October
7
,
2021
Rain Therapeutics Presents Data on Milademetan (RAIN-32) at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Download PDf
October
4
,
2021
Rain Therapeutics to Present on Milademetan at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Download PDf
September
22
,
2021
Rain Therapeutics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
Download PDf
September
9
,
2021
Rain Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference
Download PDf
September
8
,
2021
Rain Therapeutics Presents Non-Clinical Data on Milademetan (RAIN-32) in Malignant Pleural Mesothelioma at the IASLC 2021 World Conference on Lung Cancer
Download PDf
September
1
,
2021
Rain Therapeutics to Present at IASLC 2021 World Conference on Lung Cancer and Participate in Panel Discussion at Citi 16th Annual Biopharma Virtual Conference
Download PDf
August
10
,
2021
Rain Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Progress
Download PDf
August
3
,
2021
Rain Therapeutics to Report Second Quarter 2021 Financial Results and Highlights of Recent Progress on August 10, 2021
Download PDf
July
20
,
2021
Rain Therapeutics Initiates Phase 3 MANTRA Clinical Trial of Milademetan for De-differentiated Liposarcoma and Provides Patient Update from Prior Clinical Program
Download PDf
June
3
,
2021
Rain Therapeutics Announces Collaboration with Tempus for Genomic Analysis in Planned MDM2-Amplified Phase 2 Basket Trial of RAIN-32
Download PDf
Previous
#
Next
